Description: Implementing State-of-the-Art, Reproducible & Predictive Oncology Models to Enhance Target Selection & Facilitate Biomarker Discovery
2023 EVENT GUIDE REGISTER INTEREST PARTNERSHIP Accelerating the Translational Race Through the Clinic with Innovative Model Platforms Over the last 12 months, we have seen many combination therapies enter Phase I and II trials with both successes and challenges, particularly in solid tumors. The FDA Modernization Act 2.0 passing has also steered biopharma away from animal models, empowering the preclinical and translational tumor models’ space to continue innovating and decrease the translational gap into t
At the 11th Annual Tumor Models Boston Summit , you gained practical insights into the latest updates through 30+ case studies across 2 dedicated tracks. We joined and met pioneers in preclinical in preclinical and translational targeted, combination oncology to advance your candidates to patients with optimized translatability, efficiency, and cost-effectiveness!
Vice President